Jack Bliss

Jack Bliss

Associate
Baker & McKenzie Services Limited
Not admitted to practice law in this jurisdiction

Biography

Jack is a senior associate in the Private Equity & Funds team in London. Jack advises on domestic and international private equity transactions (including buyouts, joint ventures, minority investments and exits) as well as domestic and international mergers and acquisitions.

Jack completed a 12-month secondment to Bain Capital Private Equity in London in 2024-2025.

Practice Focus

Jack's practice focuses on advising financial sponsors generally, complemented by a strong focus on TMT, digital infrastructure and software transactions and clients.

Representative Legal Matters

  • Advised Bain Capital portfolio company Namirial on the acquisition of Signaturit, a cloud-based digital transaction management provider, from PSG Equity.
  • Advised Colt Technology Services Group on its USD 1.8 billion acquisition of the EMEA businesses of Lumen Technologies, Inc., a US listed company.
  • Advised Cellnex Telecoms, S.A. on its EUR 730 million divestment of a 49% stake in its Nordics telecom towers business to Stonepeak.
  • Advised New Mountain Capital on its USD 2.5 billion acquisition of the Applied, Food and Enterprise Services business of PerkinElmer, Inc., a US listed company.
  • Advised Arcus Infrastructure Partners on the restructuring of its European cold storage solutions portfolio group (valued north of EUR 1 billion), including a management equity roll-up, and various bolt-on acquisitions to same.
  • Advised Gulf Data Hub on the partial divestment to, and strategic partnership with, KKR of its Middle East data centre business. 
  • Advised Coats Group plc on its USD 770 million acquisition of OrthoLite via competitive auction.
  • Advised PETRONAS Chemical Group on its EUR 1.6 billion acquisition of the Perstorp Group, a leading sustainability-driven global specialty chemicals company.

Whilst on secondment to Bain Capital Private Equity, advised Bain Capital on a number of acquisitions and divestments, including:

  • the acquisition of a controlling stake in Somacis, an Italian-headquartered manufacturer of printed circuit boards, from Chequers Capital, and the subsequent add-on acquisition of the AT&S Korea, a medical PCB manufacturer
  • the EUR 4 billion acquisition of Apleona, a leading European provider of integrated facility management, from PAI Partners
  • the acquisition of a controlling stake in Namirial, a leading provider of digital transaction management software solutions, from Ambienta
  • the acquisition of a controlling stake in Softway Medical Group, a European healthcare software provider, from Five Arrows and Naxicap Partners
  • the acquisition by Bain Capital portfolio company Valeo Foods of I.D.C. Holding, a major manufacturer of high-quality sweets products in Slovakia
  • the GBP 1.3 billion sale of esure, a leading UK personal lines insurer, to Ageas

Admissions

  • Supreme Court of New South Wales~Australia (2019)

Education

  • University of Sydney (Juris Doctor) (2019)
  • University of Sydney (Bachelor of International & Global Studies) (2016)

Languages

  • English